Celsius Therapeutics Company
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Medical BioTech
Investors Number:
11.0
Last Funding Date:
2022-03-24
Technology:
['BioTech & HealthTech']
Founded Date:
2018-01-01
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
148000000.0
Last Funding Type:
Series B
Employee Number:
45200